Provided by Tiger Fintech (Singapore) Pte. Ltd.

Catalyst Pharmaceuticals

21.05
+0.10000.48%
Volume:660.36K
Turnover:13.84M
Market Cap:2.57B
PE:13.42
High:21.37
Open:21.10
Low:20.71
Close:20.95
Loading ...

Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
05 Apr

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
03 Apr

What Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice?

Insider Monkey
·
02 Apr

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
02 Apr

Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
01 Apr

Catalyst (CPRX) Up 14.7% Since Last Earnings Report: Can It Continue?

Zacks
·
28 Mar

Jim Cramer on Catalyst Pharmaceuticals (CPRX): ‘That’s My Kind of Stock!’

Insider Monkey
·
27 Mar

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
27 Mar

With 81% ownership in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), institutional investors have a lot riding on the business

Simply Wall St.
·
26 Mar

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?

Zacks
·
25 Mar

Catalyst Pharmaceuticals Inc. Stock Advances 6.2%, Outperforms Competitors

Dow Jones
·
25 Mar

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
21 Mar

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Mar

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Zacks
·
17 Mar

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Healthcare Stock For Long-Term Investment?

Insider Monkey
·
14 Mar

Truist Financial Keeps Their Buy Rating on Catalyst Pharma (CPRX)

TIPRANKS
·
14 Mar

Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
14 Mar

Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
11 Mar

Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
07 Mar

We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Robust Earnings Are Conservative

Simply Wall St.
·
05 Mar